Healthcare Services

Global Dupuytren’s Disease Market Forecast Highlighting Expansion And Competitive Dynamics

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Dupuytren’s Disease Market?

The dupuytren’s disease market size has shown considerable growth in recent years. It is anticipated to increase from $4.51 billion in 2025 to $4.76 billion in 2026, with a compound annual growth rate (CAGR) of 5.7%. The historical expansion can be attributed to the rise in the aging population, the widespread occurrence of orthopedic disorders, the accessibility of surgical treatments, the standardization of clinical diagnoses, and the increasing adoption of hand therapy.

The market size for dupuytren’s disease is anticipated to show significant expansion over the next few years. It is projected to reach $5.94 billion by 2030, with a compound annual growth rate (CAGR) of 5.7%. This expected growth during the forecast period can be linked to the progression of biologic therapies, advancements in minimally invasive techniques, the broadening of outpatient care, an increased emphasis on patient quality of life, and the development of rehabilitation services. Prominent trends observed in the forecast period encompass the increasing acceptance of minimally invasive treatment approaches, a rise in the application of enzyme injection therapies, a growing inclination towards outpatient surgical procedures, the expansion of early diagnosis and physical examination methods, and an amplified focus on post-treatment rehabilitation.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21944&type=smp

Which Major Factors Are Contributing To The Development Of The Dupuytren’s Disease Market?

The increasing prevalence of minimally invasive treatments is anticipated to drive the expansion of the Dupuytren’s disease market in the future. These treatments encompass medical procedures executed with minimal incisions or tissue disruption, leading to less pain, quicker recovery times, and reduced scarring. Their adoption is growing as both patients and medical professionals favor methods offering shorter healing periods, decreased discomfort, and lower complication rates when contrasted with conventional open surgeries. The Dupuytren’s disease market caters to this demand by providing minimally invasive choices that improve hand functionality, alleviate finger contractures, and boost recovery results for those impacted. As an illustration, in June 2024, data from the American Society of Plastic Surgeons, a US-based non-profit organization, indicated that minimally invasive procedures saw a 7% increase in 2023, surpassing the growth rate of surgical procedures by 2%. Specific hand surgeries like carpal tunnel, arthritis, and trigger finger reached a total of 207,887 procedures, marking a 2% increase from 2022. Consequently, the expansion of minimally invasive treatments is fueling the growth of the Dupuytren’s disease market.

How Is Segment Classification Applied In The Dupuytren’s Disease Market?

The dupuytren’s disease market covered in this report is segmented –

1) By Disease Type: Type I, Type II, Type III

2) By Treatment: Surgery, Radiation Therapy, Needle Aponeurotomy, Steroid Shot, Enzyme Injection, Occupational Therapy, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Diagnosis: Physical Examination, X-Ray, Other Diagnosis

5) By End-User: Hospitals, Clinics, Academic And Research Institute, Other End-Users

Subsegments:

1) By Type I: Classical Dupuytren’s Disease, Familial Dupuytren’s Disease

2) By Type II: Palmar Fasciitis, Ledderhose Disease

3) By Type III: Garrod’s Pads, Peyronie’s Disease

Which Trends Are Expected To Shape The Dupuytren’s Disease Market?

Leading companies in the Dupuytren’s disease market are concentrating on initiating clinical studies to create innovative, primary, disease-modifying therapies designed to halt or reverse the advancement of fibrosis. These trials are organized research investigations that evaluate the safety, effectiveness, and possible adverse reactions of new medications, treatments, or medical interventions in human subjects prior to receiving regulatory clearance and broader clinical application. As an illustration, in April 2023, Ventoux Biosciences, an American biopharmaceutical entity focused on non-surgical treatments for Dupuytren’s disease, reported encouraging preclinical outcomes for its primary fibrosis therapy, VEN-201. This drug, a repurposed existing commercial medication, showed effectiveness in reducing skin fibrosis within mouse models of Dupuytren’s contracture. These encouraging findings led the company to commence fundraising activities to progress VEN-201 into clinical development, positioning it as a prospective disease-modifying treatment.

Who Are The Major Companies Operating In The Dupuytren’s Disease Market?

Major companies operating in the dupuytren’s disease market are Pfizer Inc., Aetna Inc., Mayo clinic, Penn Medicine, Mercy Health, Endo Inc., Resilience Orthopedics, Raleigh Orthopaedic, Hoag Orthopedic Institute, OSS Health, Connext Inc., University of Utah Health, Ventoux Biosciences Inc., Auxilium Pharmaceuticals, 180 Life Sciences Corp., Brigid Freyne MD, Nantong Jinghua Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Actiza Pharmaceutical Private Limited, Spear Pharmaceuticals

Access The Complete Dupuytren’s Disease Market Report:

https://www.thebusinessresearchcompany.com/report/dupuytrens-disease-global-market-report

Which Regional Market Leads The Dupuytren’s Disease Market?

North America was the largest region in the dupuytren’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dupuytren’s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Dupuytren’s Disease Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21944&type=smp

Browse Through More Reports Similar to the Global Dupuytren’s Disease Market 2026, By The Business Research Company

Rare Diseases Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Neurological Disease Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Peripheral Arterial Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795